Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilators for exertional dyspnea in pulmonary arterial hypertension
2014-002590-10Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ipratropium bromide and salbutamol in pulmonary arterial hypertension (PAH) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2016; status: completed.
02
Drugs
ipratropium bromidesalbutamol
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2014-002590-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002590-10.